BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37639029)

  • 1. Omission of Completion Lymph Node Dissection in Sentinel Node Biopsy Positive Head and Neck Cutaneous Melanoma Patients.
    Kesmodel SB; Kronenfeld JP; Zhao W; Koru-Sengul T; Goel N; Weingrad DN; Hernandez-Aya L; Lutzky J; Feun L; Garland-Kledzik M; Crystal JS
    Ann Surg Oncol; 2023 Nov; 30(12):7671-7685. PubMed ID: 37639029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
    Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
    J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Practice Patterns in the Management of the Regional Lymph Node Basin After Positive Sentinel Lymph Node Biopsy for Cutaneous Melanoma.
    Sharon CE; Straker RJ; Li EH; Karakousis GC; Miura JT
    Ann Surg Oncol; 2022 Dec; 29(13):8456-8464. PubMed ID: 36006494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Stage Migration Occur as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma?
    Senders ZJ; Bartlett EK; Mouw TJ; McMasters KM; Egger ME
    Ann Surg Oncol; 2023 Jun; 30(6):3648-3654. PubMed ID: 36934378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
    Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
    Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
    J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
    Fritsch VA; Cunningham JE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and Safety.
    Hanks JE; Kovatch KJ; Ali SA; Roberts E; Durham AB; Smith JD; Bradford CR; Malloy KM; Boonstra PS; Lao CD; McLean SA
    Otolaryngol Head Neck Surg; 2020 Apr; 162(4):520-529. PubMed ID: 32041486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Sinnamon AJ; Song Y; Sharon CE; Yang YX; Elder DE; Zhang PJ; Xu X; Roses RE; Kelz RR; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Adoption and Outcomes of Nodal Observation for Patients with Melanoma and Sentinel Lymph Node Metastases.
    Parvez E; Khosrow-Khavar F; Dumitra T; Nessim C; Bernard-Bédard É; Rivard J; Pravong V; Wang S; Gervais MK; Meterissian S; Dumitra S
    Ann Surg Oncol; 2023 Feb; 30(2):1195-1205. PubMed ID: 36282456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey.
    Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
    J Plast Reconstr Aesthet Surg; 2024 Apr; 91():167-172. PubMed ID: 38417393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma sentinel lymph node biopsy and completion lymph node dissection: A regional hospital experience.
    Williams TS; Tallon B; Adams BM
    J Plast Reconstr Aesthet Surg; 2022 Feb; 75(2):730-736. PubMed ID: 34789434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the positive sentinel lymph node in the post-MSLT-II era.
    Bredbeck BC; Mubarak E; Zubieta DG; Tesorero R; Holmes AR; Dossett LA; VanKoevering KK; Durham AB; Hughes TM
    J Surg Oncol; 2020 Dec; 122(8):1778-1784. PubMed ID: 32893366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
    Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
    Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Completion node dissection in patients with sentinel node-positive melanoma of the head and neck.
    Smith VA; Cunningham JE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Apr; 146(4):591-9. PubMed ID: 22237296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National practice patterns of completion lymph node dissection for sentinel node-positive melanoma.
    Hewitt DB; Merkow RP; DeLancey JO; Wayne JD; Hyngstrom JR; Russell MC; Gerami P; Balch CM; Bilimoria KY
    J Surg Oncol; 2018 Sep; 118(3):493-500. PubMed ID: 30098302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
    Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Outcomes Between Surveillance Ultrasound and Completion Lymph Node Dissection in Children and Adolescents With Sentinel Lymph Node-Positive Cutaneous Melanoma.
    Scoville SD; Stanek JR; Rinehardt H; Sutthatarn P; Abdelhafeez AH; Talbot LJ; Malek M; Leraas HJ; Tracy ET; Chen SY; Kim ES; Lotakis DM; Ehrlich PF; Favela JG; Le HD; Davidson J; Wilson CA; Seemann NM; Osman Y; Piche N; Hoang V; Petroze RT; Polites SF; McKay KG; Correa H; Lovvorn HN; Lee YM; Balagani A; Dasgupta R; Aldrink JH
    Ann Surg; 2024 Mar; 279(3):536-541. PubMed ID: 37487006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Completion Lymph Node Dissection for Melanoma Before and After the Multicenter Selective Lymphadenectomy Trial-II in the United States.
    Castle JT; Adatorwovor R; Levy BE; Marcinkowski EF; Merritt A; Stapleton JL; Burke EE
    Ann Surg Oncol; 2023 Feb; 30(2):1184-1193. PubMed ID: 36331660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?
    Puza CJ; Josyula S; Terando AM; Howard JH; Agnese DM; Mosca PJ; Lee WT; Beasley GM
    J Surg Oncol; 2018 Jun; 117(7):1584-1588. PubMed ID: 29513892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.